カテゴリ： 世界, 医療/バイオ, QYResearch

認知機能低下の世界市場インサイト・予測（～2028年）

■ 英語タイトル：Global Cognitive Decline Market Insights, Forecast to 2028

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QY22JL3856）■ 発行会社/調査会社：QYResearch
■ 商品コード：QY22JL3856
■ 発行日：2022年7月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：126
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥725,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,087,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,450,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[認知機能低下の世界市場インサイト・予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

COVID-19のパンデミックにより、認知機能低下のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に認知機能低下の世界市場のxxx％を占める「コリンエステラーゼ阻害剤」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「軽度認知障害（MCI）」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
認知機能低下の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの認知機能低下市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

認知機能低下のグローバル主要企業には、Stryker、Smith & Nephew、Hill-Rom Services Inc.、Paramount Bed Holdings Co., Ltd.、ArjoHuntleigh、Talley Group Limited、Drive DeVilbiss Healthcare Ltd (Sidhil Limited)、Apex Medical Corp.、Medtronic、PROMA REHA, s. r. o.、Linet spol. S R.O.、DARCO International、DeRoyal Industries、BSN Medical (Essity)、Mölnlycke Health Care、TrueKAST (Wound Kair Concepts)、Thuasne SAS、DJO Global、ORTHOSERVICE AG、Breg, Inc.、Advanced Orthopaedics、ALGEOS、Hollister Incorporated、ConvaTec Group plc、Coloplast A/S、Medline Industries Inc.、Invacare Corporationなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

認知機能低下市場は、種類と用途によって区分されます。世界の認知機能低下市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
コリンエステラーゼ阻害剤、NMDA受容体拮抗薬

【用途別セグメント】
軽度認知障害（MCI）、認知症

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 認知機能低下製品概要
- 種類別市場（コリンエステラーゼ阻害剤、NMDA受容体拮抗薬）
- 用途別市場（軽度認知障害（MCI）、認知症）
- 調査の目的
・エグゼクティブサマリー
- 世界の認知機能低下販売量予測2017-2028
- 世界の認知機能低下売上予測2017-2028
- 認知機能低下の地域別販売量
- 認知機能低下の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別認知機能低下販売量
- 主要メーカー別認知機能低下売上
- 主要メーカー別認知機能低下価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（コリンエステラーゼ阻害剤、NMDA受容体拮抗薬）
- 認知機能低下の種類別販売量
- 認知機能低下の種類別売上
- 認知機能低下の種類別価格
・用途別市場規模（軽度認知障害（MCI）、認知症）
- 認知機能低下の用途別販売量
- 認知機能低下の用途別売上
- 認知機能低下の用途別価格
・北米市場
- 北米の認知機能低下市場規模（種類別、用途別）
- 主要国別の認知機能低下市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの認知機能低下市場規模（種類別、用途別）
- 主要国別の認知機能低下市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の認知機能低下市場規模（種類別、用途別）
- 主要国別の認知機能低下市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の認知機能低下市場規模（種類別、用途別）
- 主要国別の認知機能低下市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの認知機能低下市場規模（種類別、用途別）
- 主要国別の認知機能低下市場規模（トルコ、サウジアラビア）
・企業情報
Stryker、Smith & Nephew、Hill-Rom Services Inc.、Paramount Bed Holdings Co., Ltd.、ArjoHuntleigh、Talley Group Limited、Drive DeVilbiss Healthcare Ltd (Sidhil Limited)、Apex Medical Corp.、Medtronic、PROMA REHA, s. r. o.、Linet spol. S R.O.、DARCO International、DeRoyal Industries、BSN Medical (Essity)、Mölnlycke Health Care、TrueKAST (Wound Kair Concepts)、Thuasne SAS、DJO Global、ORTHOSERVICE AG、Breg, Inc.、Advanced Orthopaedics、ALGEOS、Hollister Incorporated、ConvaTec Group plc、Coloplast A/S、Medline Industries Inc.、Invacare Corporation
・産業チェーン及び販売チャネル分析
- 認知機能低下の産業チェーン分析
- 認知機能低下の原材料
- 認知機能低下の生産プロセス
- 認知機能低下の販売及びマーケティング
- 認知機能低下の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 認知機能低下の産業動向
- 認知機能低下のマーケットドライバー
- 認知機能低下の課題
- 認知機能低下の阻害要因
・主な調査結果

Market Analysis and Insights: Global Cognitive Decline Market
The global Cognitive Decline market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, by Drug Therapy accounting for % of the Cognitive Decline global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Mild Cognitive Impairment (MCI) segment is altered to an % CAGR throughout this forecast period.
China Cognitive Decline market size is valued at US$ million in 2021, while the North America and Europe Cognitive Decline are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Cognitive Decline landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cognitive Decline market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cognitive Decline market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cognitive Decline market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cognitive Decline market.
Global Cognitive Decline Scope and Market Size
Cognitive Decline market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cognitive Decline market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
by Drug Therapy
Cholinesterase Inhibitors
NMDA receptor antagonists
by Non-Invasive Stimulation Devices
Vagus Nerve Stimulators
Deep Brain Stimulators
Transcranial Magnetic Stimulators (TMSs)
Segment by Application
Mild Cognitive Impairment (MCI)
Dementia
By Company
Stryker
Smith & Nephew
Hill-Rom Services Inc.
Paramount Bed Holdings Co., Ltd.
ArjoHuntleigh
Talley Group Limited
Drive DeVilbiss Healthcare Ltd (Sidhil Limited)
Apex Medical Corp.
Medtronic
PROMA REHA, s. r. o.
Linet spol. S R.O.
DARCO International
DeRoyal Industries
BSN Medical (Essity)
Mölnlycke Health Care
TrueKAST (Wound Kair Concepts)
Thuasne SAS
DJO Global
ORTHOSERVICE AG
Breg, Inc.
Advanced Orthopaedics
ALGEOS
Hollister Incorporated
ConvaTec Group plc
Coloplast A/S
Medline Industries Inc.
Invacare Corporation
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

*** レポート目次（コンテンツ）***

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cognitive Decline Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Cholinesterase Inhibitors
1.2.3 NMDA receptor antagonists
1.3 Market by Application
1.3.1 Global Cognitive Decline Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Mild Cognitive Impairment (MCI)
1.3.3 Dementia
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cognitive Decline Market Perspective (2017-2028)
2.2 Cognitive Decline Growth Trends by Region
2.2.1 Cognitive Decline Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cognitive Decline Historic Market Size by Region (2017-2022)
2.2.3 Cognitive Decline Forecasted Market Size by Region (2023-2028)
2.3 Cognitive Decline Market Dynamics
2.3.1 Cognitive Decline Industry Trends
2.3.2 Cognitive Decline Market Drivers
2.3.3 Cognitive Decline Market Challenges
2.3.4 Cognitive Decline Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cognitive Decline Players by Revenue
3.1.1 Global Top Cognitive Decline Players by Revenue (2017-2022)
3.1.2 Global Cognitive Decline Revenue Market Share by Players (2017-2022)
3.2 Global Cognitive Decline Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cognitive Decline Revenue
3.4 Global Cognitive Decline Market Concentration Ratio
3.4.1 Global Cognitive Decline Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cognitive Decline Revenue in 2021
3.5 Cognitive Decline Key Players Head office and Area Served
3.6 Key Players Cognitive Decline Product Solution and Service
3.7 Date of Enter into Cognitive Decline Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cognitive Decline Breakdown Data by Type
4.1 Global Cognitive Decline Historic Market Size by Type (2017-2022)
4.2 Global Cognitive Decline Forecasted Market Size by Type (2023-2028)
5 Cognitive Decline Breakdown Data by Application
5.1 Global Cognitive Decline Historic Market Size by Application (2017-2022)
5.2 Global Cognitive Decline Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cognitive Decline Market Size (2017-2028)
6.2 North America Cognitive Decline Market Size by Type
6.2.1 North America Cognitive Decline Market Size by Type (2017-2022)
6.2.2 North America Cognitive Decline Market Size by Type (2023-2028)
6.2.3 North America Cognitive Decline Market Share by Type (2017-2028)
6.3 North America Cognitive Decline Market Size by Application
6.3.1 North America Cognitive Decline Market Size by Application (2017-2022)
6.3.2 North America Cognitive Decline Market Size by Application (2023-2028)
6.3.3 North America Cognitive Decline Market Share by Application (2017-2028)
6.4 North America Cognitive Decline Market Size by Country
6.4.1 North America Cognitive Decline Market Size by Country (2017-2022)
6.4.2 North America Cognitive Decline Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cognitive Decline Market Size (2017-2028)
7.2 Europe Cognitive Decline Market Size by Type
7.2.1 Europe Cognitive Decline Market Size by Type (2017-2022)
7.2.2 Europe Cognitive Decline Market Size by Type (2023-2028)
7.2.3 Europe Cognitive Decline Market Share by Type (2017-2028)
7.3 Europe Cognitive Decline Market Size by Application
7.3.1 Europe Cognitive Decline Market Size by Application (2017-2022)
7.3.2 Europe Cognitive Decline Market Size by Application (2023-2028)
7.3.3 Europe Cognitive Decline Market Share by Application (2017-2028)
7.4 Europe Cognitive Decline Market Size by Country
7.4.1 Europe Cognitive Decline Market Size by Country (2017-2022)
7.4.2 Europe Cognitive Decline Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cognitive Decline Market Size (2017-2028)
8.2 Asia-Pacific Cognitive Decline Market Size by Type
8.2.1 Asia-Pacific Cognitive Decline Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cognitive Decline Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cognitive Decline Market Share by Type (2017-2028)
8.3 Asia-Pacific Cognitive Decline Market Size by Application
8.3.1 Asia-Pacific Cognitive Decline Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cognitive Decline Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cognitive Decline Market Share by Application (2017-2028)
8.4 Asia-Pacific Cognitive Decline Market Size by Region
8.4.1 Asia-Pacific Cognitive Decline Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cognitive Decline Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cognitive Decline Market Size (2017-2028)
9.2 Latin America Cognitive Decline Market Size by Type
9.2.1 Latin America Cognitive Decline Market Size by Type (2017-2022)
9.2.2 Latin America Cognitive Decline Market Size by Type (2023-2028)
9.2.3 Latin America Cognitive Decline Market Share by Type (2017-2028)
9.3 Latin America Cognitive Decline Market Size by Application
9.3.1 Latin America Cognitive Decline Market Size by Application (2017-2022)
9.3.2 Latin America Cognitive Decline Market Size by Application (2023-2028)
9.3.3 Latin America Cognitive Decline Market Share by Application (2017-2028)
9.4 Latin America Cognitive Decline Market Size by Country
9.4.1 Latin America Cognitive Decline Market Size by Country (2017-2022)
9.4.2 Latin America Cognitive Decline Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cognitive Decline Market Size (2017-2028)
10.2 Middle East & Africa Cognitive Decline Market Size by Type
10.2.1 Middle East & Africa Cognitive Decline Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cognitive Decline Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cognitive Decline Market Share by Type (2017-2028)
10.3 Middle East & Africa Cognitive Decline Market Size by Application
10.3.1 Middle East & Africa Cognitive Decline Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cognitive Decline Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cognitive Decline Market Share by Application (2017-2028)
10.4 Middle East & Africa Cognitive Decline Market Size by Country
10.4.1 Middle East & Africa Cognitive Decline Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cognitive Decline Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Stryker
11.1.1 Stryker Company Details
11.1.2 Stryker Business Overview
11.1.3 Stryker Cognitive Decline Introduction
11.1.4 Stryker Revenue in Cognitive Decline Business (2017-2022)
11.1.5 Stryker Recent Developments
11.2 Smith & Nephew
11.2.1 Smith & Nephew Company Details
11.2.2 Smith & Nephew Business Overview
11.2.3 Smith & Nephew Cognitive Decline Introduction
11.2.4 Smith & Nephew Revenue in Cognitive Decline Business (2017-2022)
11.2.5 Smith & Nephew Recent Developments
11.3 Hill-Rom Services Inc.
11.3.1 Hill-Rom Services Inc. Company Details
11.3.2 Hill-Rom Services Inc. Business Overview
11.3.3 Hill-Rom Services Inc. Cognitive Decline Introduction
11.3.4 Hill-Rom Services Inc. Revenue in Cognitive Decline Business (2017-2022)
11.3.5 Hill-Rom Services Inc. Recent Developments
11.4 Paramount Bed Holdings Co., Ltd.
11.4.1 Paramount Bed Holdings Co., Ltd. Company Details
11.4.2 Paramount Bed Holdings Co., Ltd. Business Overview
11.4.3 Paramount Bed Holdings Co., Ltd. Cognitive Decline Introduction
11.4.4 Paramount Bed Holdings Co., Ltd. Revenue in Cognitive Decline Business (2017-2022)
11.4.5 Paramount Bed Holdings Co., Ltd. Recent Developments
11.5 ArjoHuntleigh
11.5.1 ArjoHuntleigh Company Details
11.5.2 ArjoHuntleigh Business Overview
11.5.3 ArjoHuntleigh Cognitive Decline Introduction
11.5.4 ArjoHuntleigh Revenue in Cognitive Decline Business (2017-2022)
11.5.5 ArjoHuntleigh Recent Developments
11.6 Talley Group Limited
11.6.1 Talley Group Limited Company Details
11.6.2 Talley Group Limited Business Overview
11.6.3 Talley Group Limited Cognitive Decline Introduction
11.6.4 Talley Group Limited Revenue in Cognitive Decline Business (2017-2022)
11.6.5 Talley Group Limited Recent Developments
11.7 Drive DeVilbiss Healthcare Ltd (Sidhil Limited)
11.7.1 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Company Details
11.7.2 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Business Overview
11.7.3 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Cognitive Decline Introduction
11.7.4 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Revenue in Cognitive Decline Business (2017-2022)
11.7.5 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Recent Developments
11.8 Apex Medical Corp.
11.8.1 Apex Medical Corp. Company Details
11.8.2 Apex Medical Corp. Business Overview
11.8.3 Apex Medical Corp. Cognitive Decline Introduction
11.8.4 Apex Medical Corp. Revenue in Cognitive Decline Business (2017-2022)
11.8.5 Apex Medical Corp. Recent Developments
11.9 Medtronic
11.9.1 Medtronic Company Details
11.9.2 Medtronic Business Overview
11.9.3 Medtronic Cognitive Decline Introduction
11.9.4 Medtronic Revenue in Cognitive Decline Business (2017-2022)
11.9.5 Medtronic Recent Developments
11.10 PROMA REHA, s. r. o.
11.10.1 PROMA REHA, s. r. o. Company Details
11.10.2 PROMA REHA, s. r. o. Business Overview
11.10.3 PROMA REHA, s. r. o. Cognitive Decline Introduction
11.10.4 PROMA REHA, s. r. o. Revenue in Cognitive Decline Business (2017-2022)
11.10.5 PROMA REHA, s. r. o. Recent Developments
11.11 Linet spol. S R.O.
11.11.1 Linet spol. S R.O. Company Details
11.11.2 Linet spol. S R.O. Business Overview
11.11.3 Linet spol. S R.O. Cognitive Decline Introduction
11.11.4 Linet spol. S R.O. Revenue in Cognitive Decline Business (2017-2022)
11.11.5 Linet spol. S R.O. Recent Developments
11.12 DARCO International
11.12.1 DARCO International Company Details
11.12.2 DARCO International Business Overview
11.12.3 DARCO International Cognitive Decline Introduction
11.12.4 DARCO International Revenue in Cognitive Decline Business (2017-2022)
11.12.5 DARCO International Recent Developments
11.13 DeRoyal Industries
11.13.1 DeRoyal Industries Company Details
11.13.2 DeRoyal Industries Business Overview
11.13.3 DeRoyal Industries Cognitive Decline Introduction
11.13.4 DeRoyal Industries Revenue in Cognitive Decline Business (2017-2022)
11.13.5 DeRoyal Industries Recent Developments
11.14 BSN Medical (Essity)
11.14.1 BSN Medical (Essity) Company Details
11.14.2 BSN Medical (Essity) Business Overview
11.14.3 BSN Medical (Essity) Cognitive Decline Introduction
11.14.4 BSN Medical (Essity) Revenue in Cognitive Decline Business (2017-2022)
11.14.5 BSN Medical (Essity) Recent Developments
11.15 Mölnlycke Health Care
11.15.1 Mölnlycke Health Care Company Details
11.15.2 Mölnlycke Health Care Business Overview
11.15.3 Mölnlycke Health Care Cognitive Decline Introduction
11.15.4 Mölnlycke Health Care Revenue in Cognitive Decline Business (2017-2022)
11.15.5 Mölnlycke Health Care Recent Developments
11.16 TrueKAST (Wound Kair Concepts)
11.16.1 TrueKAST (Wound Kair Concepts) Company Details
11.16.2 TrueKAST (Wound Kair Concepts) Business Overview
11.16.3 TrueKAST (Wound Kair Concepts) Cognitive Decline Introduction
11.16.4 TrueKAST (Wound Kair Concepts) Revenue in Cognitive Decline Business (2017-2022)
11.16.5 TrueKAST (Wound Kair Concepts) Recent Developments
11.17 Thuasne SAS
11.17.1 Thuasne SAS Company Details
11.17.2 Thuasne SAS Business Overview
11.17.3 Thuasne SAS Cognitive Decline Introduction
11.17.4 Thuasne SAS Revenue in Cognitive Decline Business (2017-2022)
11.17.5 Thuasne SAS Recent Developments
11.18 DJO Global
11.18.1 DJO Global Company Details
11.18.2 DJO Global Business Overview
11.18.3 DJO Global Cognitive Decline Introduction
11.18.4 DJO Global Revenue in Cognitive Decline Business (2017-2022)
11.18.5 DJO Global Recent Developments
11.19 ORTHOSERVICE AG
11.19.1 ORTHOSERVICE AG Company Details
11.19.2 ORTHOSERVICE AG Business Overview
11.19.3 ORTHOSERVICE AG Cognitive Decline Introduction
11.19.4 ORTHOSERVICE AG Revenue in Cognitive Decline Business (2017-2022)
11.19.5 ORTHOSERVICE AG Recent Developments
11.20 Breg, Inc.
11.20.1 Breg, Inc. Company Details
11.20.2 Breg, Inc. Business Overview
11.20.3 Breg, Inc. Cognitive Decline Introduction
11.20.4 Breg, Inc. Revenue in Cognitive Decline Business (2017-2022)
11.20.5 Breg, Inc. Recent Developments
11.21 Advanced Orthopaedics
11.21.1 Advanced Orthopaedics Company Details
11.21.2 Advanced Orthopaedics Business Overview
11.21.3 Advanced Orthopaedics Cognitive Decline Introduction
11.21.4 Advanced Orthopaedics Revenue in Cognitive Decline Business (2017-2022)
11.21.5 Advanced Orthopaedics Recent Developments
11.22 ALGEOS
11.22.1 ALGEOS Company Details
11.22.2 ALGEOS Business Overview
11.22.3 ALGEOS Cognitive Decline Introduction
11.22.4 ALGEOS Revenue in Cognitive Decline Business (2017-2022)
11.22.5 ALGEOS Recent Developments
11.23 Hollister Incorporated
11.23.1 Hollister Incorporated Company Details
11.23.2 Hollister Incorporated Business Overview
11.23.3 Hollister Incorporated Cognitive Decline Introduction
11.23.4 Hollister Incorporated Revenue in Cognitive Decline Business (2017-2022)
11.23.5 Hollister Incorporated Recent Developments
11.24 ConvaTec Group plc
11.24.1 ConvaTec Group plc Company Details
11.24.2 ConvaTec Group plc Business Overview
11.24.3 ConvaTec Group plc Cognitive Decline Introduction
11.24.4 ConvaTec Group plc Revenue in Cognitive Decline Business (2017-2022)
11.24.5 ConvaTec Group plc Recent Developments
11.25 Coloplast A/S
11.25.1 Coloplast A/S Company Details
11.25.2 Coloplast A/S Business Overview
11.25.3 Coloplast A/S Cognitive Decline Introduction
11.25.4 Coloplast A/S Revenue in Cognitive Decline Business (2017-2022)
11.25.5 Coloplast A/S Recent Developments
11.26 Medline Industries Inc.
11.26.1 Medline Industries Inc. Company Details
11.26.2 Medline Industries Inc. Business Overview
11.26.3 Medline Industries Inc. Cognitive Decline Introduction
11.26.4 Medline Industries Inc. Revenue in Cognitive Decline Business (2017-2022)
11.26.5 Medline Industries Inc. Recent Developments
11.27 Invacare Corporation
11.27.1 Invacare Corporation Company Details
11.27.2 Invacare Corporation Business Overview
11.27.3 Invacare Corporation Cognitive Decline Introduction
11.27.4 Invacare Corporation Revenue in Cognitive Decline Business (2017-2022)
11.27.5 Invacare Corporation Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 認知機能低下のグローバル市場展望 2023年-2029年：リンエステラーゼ阻害剤、NMDA受容体拮抗薬
  • 認知障害治療の世界市場2023年：抗てんかん薬認知障害治療、抗精神病薬認知障害治療
  • 脳震盪の世界市場2023年：治療、診断
  • 速溶性フィルムの世界市場インサイト・予測（～2028年）
  • CD47（IAP）の世界市場インサイト・予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QY22JL3856 )"認知機能低下の世界市場インサイト・予測（～2028年）" (英文：Global Cognitive Decline Market Insights, Forecast to 2028)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。